HU9501479D0 - Displacement chromatography process and purified hemoglobin product - Google Patents

Displacement chromatography process and purified hemoglobin product

Info

Publication number
HU9501479D0
HU9501479D0 HU9501479A HU9501479A HU9501479D0 HU 9501479 D0 HU9501479 D0 HU 9501479D0 HU 9501479 A HU9501479 A HU 9501479A HU 9501479 A HU9501479 A HU 9501479A HU 9501479 D0 HU9501479 D0 HU 9501479D0
Authority
HU
Hungary
Prior art keywords
hemoglobin
column
admixtures
stage
chromatography process
Prior art date
Application number
HU9501479A
Other languages
Hungarian (hu)
Other versions
HU218159B (en
HUT72924A (en
Inventor
Diana Pliura
Diane Wiffen
Salman Ashraf
Anthony A Magnin
Original Assignee
Hemosol Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002106612A external-priority patent/CA2106612C/en
Application filed by Hemosol Inc filed Critical Hemosol Inc
Publication of HU9501479D0 publication Critical patent/HU9501479D0/en
Publication of HUT72924A publication Critical patent/HUT72924A/en
Publication of HU218159B publication Critical patent/HU218159B/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/422—Displacement mode
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention relates to the chromatographic purification of hemoglobin. The method for purifying hemoglobin from the raw solution containing the admixture of proteinaceous origin provides for the use of ion-exchange chromatography. The raw solution containing 0.1-20% hemoglobin. At the first stage, anion-exchanging column is used when the admixtures are more acidic than hemoglobin, or cation-exchanging column is used when the admixtures are more alkaline than hemoglobin. The continuous flow of the solution results first in the complete saturation of the column with hemoglobin and the admixtures with high affinity to the column, then the column is overloaded following the substitution of hemoglobin. At the second stage, the ion-exchanger alternative to that used at the first stage is employed. Again, upon the complete saturation and overloading of the column, hemoglobin is substituted.
HU9501479A 1993-09-21 1994-09-20 Displacement chromatography process for production of purified hemoglobin product HU218159B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002106612A CA2106612C (en) 1993-09-21 1993-09-21 Displacement chromatography process
PCT/CA1994/000514 WO1995008574A1 (en) 1993-09-21 1994-09-20 Displacement chromatography process and purified hemoglobin product

Publications (3)

Publication Number Publication Date
HU9501479D0 true HU9501479D0 (en) 1995-07-28
HUT72924A HUT72924A (en) 1996-06-28
HU218159B HU218159B (en) 2000-06-28

Family

ID=4152343

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9501479A HU218159B (en) 1993-09-21 1994-09-20 Displacement chromatography process for production of purified hemoglobin product

Country Status (9)

Country Link
JP (1) JP4057049B2 (en)
KR (1) KR100361894B1 (en)
AT (1) ATE175975T1 (en)
DE (1) DE69416103T2 (en)
DK (1) DK0668877T3 (en)
ES (1) ES2126775T3 (en)
HU (1) HU218159B (en)
RU (1) RU2145873C1 (en)
UA (1) UA35599C2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2439875B (en) * 2005-04-22 2010-10-20 Waters Investments Ltd Apparatus and methods for mass spectrometric directed purification of biopolymers
RU2573894C2 (en) 2009-08-06 2016-01-27 Дженентек, Инк. Method for improving process of elimination of viruses in protein purification
AU2011329053A1 (en) * 2010-11-15 2013-06-06 Biogen Inc. Enrichment and concentration of select product isoforms by overloaded bind and elute chromatography
IL267585B (en) * 2011-12-22 2022-09-01 Genentech Inc Ion exchange membrane chromatography
BR112015027812B1 (en) * 2013-05-06 2021-03-30 Sanofi METHOD FOR PURIFYING A PROTEIN FROM A SOLUTION
TW202128264A (en) * 2019-09-25 2021-08-01 瑞士商赫孚孟拉羅股份公司 Cation chromatography using predicted elution buffer salt concentration
CN114712894B (en) * 2022-04-08 2024-04-30 无锡博慧斯生物医药科技有限公司 Activating solution, activating method and application of glycosylated hemoglobin chromatographic column

Also Published As

Publication number Publication date
DK0668877T3 (en) 1999-09-13
JPH08503714A (en) 1996-04-23
KR100361894B1 (en) 2003-05-12
HU218159B (en) 2000-06-28
RU2145873C1 (en) 2000-02-27
ES2126775T3 (en) 1999-04-01
ATE175975T1 (en) 1999-02-15
JP4057049B2 (en) 2008-03-05
RU95112503A (en) 1996-12-20
DE69416103T2 (en) 1999-08-05
UA35599C2 (en) 2001-04-16
DE69416103D1 (en) 1999-03-04
HUT72924A (en) 1996-06-28

Similar Documents

Publication Publication Date Title
GR3032728T3 (en) Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions
ATE338059T1 (en) PURIFICATION OF ECHINOCANDIN CYCLOPEPTIDES
FR2603581A1 (en) PROCESS FOR ISOLATING AND PURIFYING AMINO ACIDS BY CHROMATOGRAPHY
CA2106612A1 (en) Displacement Chromatography Process
IL139035A0 (en) Protein purification by ion exchange chromatography
SE9603068D0 (en) Process for purifying a protein
HUT72924A (en) Displacement chromatography process and purified hemoglobin product
MY108512A (en) Method of purifying protein
ES8302017A1 (en) Method of producing a factor-VIII(AHF)-high-concentrate
HUT64777A (en) Method for producing virus-safe vii factor of high purity
AU2253392A (en) Therapeutic fragments of von willebrand factor
KR960004367A (en) Preparation method of α1-antichymotrypsin
IL87543A0 (en) Interleukin 1 inhibitors,methods for the purification thereof and pharmaceutical compositions containing the same
EP0282363A3 (en) Method for preparation of a concentrate of alpha-1-antitrypsin from a human plasma fraction, and its use as a pharmaceutical
Hansson et al. Adsorption and desorption of proteins in metal chelate affinity chromatography: purification of albumin
CA2274241A1 (en) A process for purifying apolipoprotein a or apolipoprotein e from human plasma
WO1999009004A3 (en) Process for preparing and/or purifying amido acid phenyl ester sulfonates
BG102663A (en) Method for the purification of thrombino-like proteases from snake poison
DE69411492T2 (en) Process for the purification of medium olefins
JPS55148098A (en) Concentration and purification of interferon
MY105082A (en) Separation process
Vasconcellos et al. Adsorption of phenylalanine from casein hydrolysates
MD726G2 (en) Process for purification of waste waters from the dyes
KR900004933A (en) Purification method of tissue plasminogen activator
ES2072184A1 (en) Protein Petroglaucin 1 from the plant Petrocoptis glaucifolia (Lag.) Boiss, process for obtaining it and its use

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees